/sites/default/files/2025-09/mauri8449_a_hand_of_a_doctor_with_glove_touching_a_virtual_co_0675fc00-2c39-41f4-a7e5-91e65df6809f_2_0.png
Guarda
12:40 - 14:00
ROUND TABLE ON HEALTH TECHNOLOGY ASSESSMENT TO PRIVATE FINANCE FOR THE INNOVATION DEVELOPMENT BY ITALIAN BIOHIGHTECH COMPANIES
Chair
11:40 am
dott. Riccardo Dentesano
Investment Manager Friulia SpA - Trieste
Co-Chair
11:50
dott. ssa Elisabetta Borello
Co-Founder - Bio4Dreams - Milano
Speakers
12:00 am
dott. Gabriele Bellon
Director - Banca di Credito Cooperativo Venezia Giulia - Trieste
12:10 am
dott. Antonio Boccia
Head of Equity Capital Markets CFO SIM – Milano
12:20 am
dott. Antonio Salera
Senior research analyst - Generali Asset Management
12:30 am
dott. Alvise Ortolani
Banca Finint
12:40 pm
dott.ssa Monica Volpin
Investment team principal – NEVA SGR
12:50 pm
ing. Francesco Menegoni
CEO – Biovalley Investments Partner SpA
01.00 – 02.00 pm LIGHT LUNCH